Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Contacera   
Auth. number : EU/2/12/144
Active substance : Meloxicam
ATC: Anatomical main group: QM - Musculo-skeletal system
Therapeutic subgroup: QM01 - Antiinflammatory and antirheumatic products
Pharmacological subgroup: QM01A - Antiinflammatory and antirheumatic products, non-steroids
Chemical subgroup: QM01AC - Oxicams
Chemical substance: QM01AC06 - meloxicam
(See WHO ATCvet Index)
Indication: Cattle:
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
For use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.
For use in the alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.
For the relief of pain associated with equine colic.
Marketing Authorisation Holder: Zoetis Belgium S.A.
rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/12/2012 Centralised - Authorisation EMEA/V/C/2612 (2012)9390 of 06/12/2012
11/04/2013 Centralised - Variation EMEA/V/C/2612/II/1
Updated with Decision(2013)3818 of 13/06/2013
17/06/2013 Centralised - Transfer Marketing Authorisation Holder EMEA/V/C/2612/T/3 (2013)3818 of 13/06/2013
27/09/2013 Centralised - Variation EMEA/V/C/2612/IB/5
Updated with Decision(2014)312 of 16/01/2014
21/01/2014 Centralised - 2-Monthly update EMEA/V/C/2612/IB/5 (2014)312 of 16/01/2014
17/02/2014 Centralised - Variation EMEA/V/C/2612/X/2 (2014)1057 of 13/02/2014
10/07/2014 Centralised - Variation EMEA/V/C/2612/IB/6
Updated with Decision(2015)5227 of 20/07/2015
23/07/2015 Centralised - Yearly update (2015)5227 of 20/07/2015
23/03/2017 Centralised - Variation EMEA/V/C/2612/IG/747
Updated with Decision(2017)7724 of 15/11/2017
16/11/2017 Centralised - Renewal EMEA/V/C/2612/R/9 (2017)7724 of 15/11/2017
18/01/2018 Corrigendum (2018)298 of 16/01/2018